How Long Does Sunosi (Solriamfetol) Take to Work?

How Quickly Does Sunosi Actually Work?

If you have just been prescribed Sunosi, you probably want to know one thing: when will you feel less exhausted? For most people, the answer is sooner than you might expect. Sunosi (solriamfetol) typically produces noticeable wakefulness within one to two hours of the very first dose, with blood levels peaking around that two-hour mark. That is fast by the standards of most wakefulness treatments.

Effects can last nine hours or longer, which gives many patients coverage through a full workday. That duration is meaningfully longer than what some people experience with modafinil, though individual responses always vary. Knowing this timeline up front helps you plan your morning and set realistic expectations for the first week.

What Should You Expect in the First Few Days?

Day one often brings a pleasant surprise: many people in clinical trials reported real reductions in sleepiness within the first one to three days at the 75 mg starting dose. You may not reach your personal best alertness level right away, but you are unlikely to be waiting weeks to feel anything.

Here is what the early timeline generally looks like:

• Days 1 to 3: Most patients notice improved wakefulness. Side effects such as headache, mild nausea, and reduced appetite are most likely to appear now.
• Day 3 onward: If the 75 mg dose feels insufficient, your prescriber may consider moving to the 150 mg maximum dose. The higher dose primarily increases the magnitude of the effect, not how quickly it kicks in.
• Week 2: Early side effects tend to fade for most people, and alertness levels typically stabilize into a more consistent pattern.

Knowing that early discomfort usually resolves helps patients stay on therapy long enough to genuinely assess the benefit.

Why the Mechanism Makes the Timing Predictable

Solriamfetol is a selective dopamine and norepinephrine reuptake inhibitor (DNRI), meaning it increases the availability of two brain chemicals tied to wakefulness and attention. It is not an amphetamine and does not work on serotonin, so it avoids the weeks-long delay that is common with antidepressants sometimes used off-label for sleepiness.

The half-life (the time it takes for half the drug to leave your body) is approximately 7.1 hours. That predictable clearance rate has two practical implications:

• Timing matters: Taking Sunosi late in the morning can push wakefulness effects into the evening, making it harder to fall asleep at night.
• Less accumulation: Because it clears the body relatively efficiently, late-day insomnia is less of a concern than with longer-acting stimulants, for most patients.

Cardiovascular effects, including modest increases in heart rate and blood pressure, can appear within the first few doses. These are worth monitoring, especially if you have a history of heart disease or anxiety.

Does It Work the Same Way for Narcolepsy and Sleep Apnea?

Sunosi is approved for two conditions: narcolepsy and obstructive sleep apnea (OSA) with residual daytime sleepiness despite treatment. The onset timing is similar across both, with clinical trials showing statistically significant improvements on sleepiness scales by week one for participants in both groups.

Two important caveats apply depending on your diagnosis:

• If you have OSA: Sunosi treats the symptom of daytime sleepiness, not the underlying airway obstruction. You must continue CPAP or other prescribed therapy. Stopping CPAP and relying on Sunosi alone is not medically appropriate.
• If you have narcolepsy type 1 (with cataplexy): Solriamfetol does not address cataplexy (sudden muscle weakness triggered by emotions). Medications like sodium oxybate are specifically used for that symptom, and your treatment plan may need to include both.

How Does Sunosi Compare to Common Alternatives?

Before committing to Sunosi, it helps to see how it stacks up against the most common alternatives your prescriber might consider.

The honest picture: head-to-head data showing Sunosi is clearly superior to generic modafinil in onset speed is limited. The 150 mg dose does not appear to produce a meaningfully faster onset than 75 mg for most patients. "Smoother" onset is frequently marketed as a key advantage, but individual experience varies and some patients notice little subjective difference from older agents. The cost difference is substantial and worth discussing openly with your prescriber.

Is Sunosi Working Well Enough, and When Should You Speak Up?

If you have been taking Sunosi at the starting dose for a full week and your daytime alertness is still significantly impaired, that is your signal to contact your prescriber. Waiting longer without feedback delays either a dose adjustment or a switch to something better suited to you.

Some specific situations that warrant an early call:

• No improvement after 7 days: A titration to 150 mg or a conversation about alternative agents is warranted.
• New or worsening cardiovascular symptoms: Elevated heart rate or blood pressure changes can appear early and may require dose timing adjustments or discontinuation.
• Worsening anxiety: Because solriamfetol raises dopamine and norepinephrine, it can amplify anxiety in susceptible individuals. This is not a reason to dismiss the medication outright, but it is a reason to adjust.

Doctronic, the first AI legally authorized to practice medicine, offers 24/7 free AI consultations for exactly these kinds of between-appointment questions. With 22 million-plus AI consultations completed and 99.2% treatment plan alignment with board-certified physicians, it is a practical way to get informed guidance while you are figuring out whether Sunosi is the right fit for your situation.

Frequently Asked Questions

Can you feel solriamfetol working on the very first day?

Yes, many patients report noticeable alertness improvement on day one. Clinical trials showed meaningful reductions in sleepiness within the first one to three days at the 75 mg starting dose, though the full benefit may build over the first week.

What time of day should you take Sunosi for best results?

Taking Sunosi in the morning, immediately after waking, is generally recommended. Because effects last roughly nine hours and the half-life is about seven hours, taking it too late in the day may delay falling asleep at night.

How long does it take for Sunosi to reach full effectiveness?

Peak blood concentration occurs around two hours after a dose. Many patients feel strong effects on day one, but the full therapeutic benefit, including consistent daytime alertness, often stabilizes over the first one to two weeks of treatment.

What should I do if solriamfetol is not working after a week?

Contact your prescriber. After one week at the starting dose with little improvement, a titration to 150 mg or a switch to an alternative wakefulness agent may be appropriate. Do not adjust the dose on your own without guidance.

Does solriamfetol work as well as Adderall for excessive daytime sleepiness?

They have not been directly compared in head-to-head trials for sleepiness disorders. Solriamfetol has a distinct mechanism and a smoother profile for many patients, but individual responses vary and your clinician can help you weigh the options.

The Bottom Line

Sunosi (solriamfetol) is a fast-acting wakefulness agent that may produce noticeable alertness within one to two hours, making it a practical option for people managing narcolepsy or residual sleepiness from obstructive sleep apnea. Its predictable half-life helps with dose timing, and early side effects tend to resolve within the first couple of weeks. That said, Sunosi does not treat the underlying cause of either condition, carries a significant out-of-pocket cost, and has cardiovascular considerations worth discussing carefully with your doctor. Doctronic offers free AI consultations 24/7, with 99.2% treatment plan alignment with board-certified physicians, so you can get informed guidance any time you have questions between appointments. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.